Los Angeles Capital Management LLC Enanta Pharmaceuticals Inc Transaction History

Los Angeles Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$43.76 - $53.11 $210,485 - $255,459	-4,810 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$41.69 - $54.95 $439,621 - $579,447	-10,545 Reduced 68.67%	4,810 $237,000
Q4 2020 Feb 04, 2021	SELL	$41.16 - $47.47 $79,233 - $91,379	-1,925 Reduced 11.14%	15,355 $646,000
Q2 2020 Aug 05, 2020	SELL	$46.37 - $57.58 $5,796 - $7,197	-125 Reduced 0.72%	17,280 $867,000
Q1 2020 May 04, 2020	SELL	$40.22 - $62.0 $728,987 - $1.12 Million	-18,125 Reduced 51.01%	17,405 $895,000
Q4 2019 Feb 07, 2020	SELL	$57.95 - $66.61 $881,535 - $1.01 Million	-15,212 Reduced 29.98%	35,530 $2.2 Million
Q3 2019 Nov 07, 2019	SELL	$60.08 - $88.17 $1.1 Million - $1.62 Million	-18,360 Reduced 26.57%	50,742 $3.05 Million
Q2 2019 Jul 29, 2019	BUY	$81.3 - $97.35 $5.18 Million - $6.21 Million	63,742 Added 1189.22%	69,102 $5.83 Million
Q1 2019 Apr 25, 2019	BUY	$69.08 - $105.66 $73,915 - $113,056	1,070 Added 24.94%	5,360 $512,000
Q4 2018 Feb 11, 2019	BUY	$65.41 - $84.65 $42,516 - $55,022	650 Added 17.86%	4,290 $304,000
Q3 2018 Nov 05, 2018	BUY	$85.46 - $126.37 $311,074 - $459,986	3,640 New	3,640 $311,000

111

21.2M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $103M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.